Part 1: Exploring the background of person-centred care across the spectrum of related cardiometabolic diseases
The Prologue: welcome and introductions
Chapter 1: Person-centred care - the evolving landscape and new horizons in obesity management
Chapter 2: Person-centred care - the need for treatment of cardiometabolic diseases
Chapter 3: Focus on PAD - synergistic strategies across ASCVD
Chapter 4: Person-centred care - heart failure for people with cardiometabolic diseases
Chapter 5: Summarising the evidence for person-centred care across cardiometabolic diseases
Part 2: Focusing in on an expanding spectrum of cardiometabolic diseases and patient phenotypes
Checking the contents page: welcome back
Chapter 6: Focus on kidneys - synergistic strategies across cardiometabolic diseases
Chapter 7: Focus on MASH - integrating emerging data into clinical pathways
Chapter 8: Focus on childhood - charting new paths in obesity management
Chapter 9: Summarising the focus and translating it into clinical practice
Part 3: Semaglutide and the path to holistic cardiometabolic disease care
Checking the contents page: welcome back
Chapter 10: The prequel to semaglutide and the evidence that started the journey
Chapter 11: The science of the cardiometabolic care - clinical evidence and perspectives
Chapter 12: The voice of the patient - hearing their call to action for personalised care
Chapter 13: Summarising the journey and exploring the
co-authors’ views
Part 4: The future chapters - advancing the management of cardiometabolic diseases
Checking the contents page: welcome back
Chapter 14: Advancements in nutrient-stimulated hormone therapies: the evolution of amylin
Chapter 15: Advancements to clinical excellence in obesity through the potential of complementary biologies
Chapter 16: Advancements across the metabolic disease continuum - expanding the evidence
Chapter 17: Advancements in the treatment toolbox - integrating amycretin
Chapter 18: Summarising the advancements and looking to a future of clinical excellence
Part 5: Innovating our heritage - once-weekly basal insulin therapy
Checking the contents page: welcome back
Chapter 19: Innovation in basal insulins - individualised treatment in focus
Chapter 20: Innovation in combination insulin therapy - benefits beyond glycaemic control
Chapter 21: Summarising the innovation for people in need of insulin
The Epilogue: summary and close